ABN AMRO Investment Solutions’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$68.7M Buy
270,314
+105,941
+64% +$24.7M 0.59% 34
2026
Q1
$40.2M Buy
164,373
+9,521
+6% +$2.22M 0.52% 46
2025
Q4
$32M Buy
154,852
+62,159
+67% +$12.3M 0.47% 44
2025
Q3
$17.2M Sell
92,693
-42,901
-32% -$7.35M 0.35% 57
2025
Q2
$20.7M Sell
135,594
-10,550
-7% -$1.62M 0.41% 53
2025
Q1
$24.2M Buy
146,144
+23,311
+19% +$3.65M 0.51% 48
2024
Q4
$17.8M Sell
122,833
-6,203
-5% -$961K 0.33% 66
2024
Q3
$20.9M Buy
129,036
+2,689
+2% +$428K 0.36% 63
2024
Q2
$18.5M Buy
126,347
+17,749
+16% +$2.64M 0.34% 63
2024
Q1
$17.2M Buy
108,598
+9,201
+9% +$1.46M 0.3% 70
2023
Q4
$15.6M Sell
99,397
-5,543
-5% -$850K 0.27% 76
2023
Q3
$16.3M Buy
104,940
+6,372
+6% +$1.05M 0.32% 72
2023
Q2
$16.3M Buy
98,568
+4,461
+5% +$720K 0.33% 79
2023
Q1
$14.6M Buy
+94,107
New +$15.2M 0.3% 87

Other funds holding JNJ

ABN AMRO Investment Solutions's JNJ Position: Q2 2026 in Review

ABN AMRO Investment Solutions increased its Johnson & Johnson (JNJ) stake by 64% in Q2 2026, buying an estimated $24.7M and bringing the position to 270,314 shares worth $68.7M. The position accounts for 0.59% of the portfolio, ranked #34.

ABN AMRO Investment Solutions first reported a position in JNJ in Q1 2023 and has held it in 14 quarters since. 4,655 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • ABN AMRO Investment Solutions held 270,314 shares of Johnson & Johnson worth $68.7M as of Q2 2026.
  • ABN AMRO Investment Solutions bought 105,941 Johnson & Johnson shares in Q2 2026, an estimated $24.7M.
  • Johnson & Johnson made up 0.59% of ABN AMRO Investment Solutions's portfolio in Q2 2026, its #34 holding.
  • ABN AMRO Investment Solutions first reported a position in Johnson & Johnson in Q1 2023 and has held it in 14 quarters since.
  • 4,655 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on ABN AMRO Investment Solutions's 13F filing for Q2 2026, filed 23 Jul 2026.